All lobbying filings
Arnold & Porter Kaye Scholer LLP
Arnold & Porter Kaye Scholer LLP filed a Q3 report for Pharmaceutical Research and Manufacturers of America (PHRMA) on October 16, 2026, reporting $290,000 in lobbying income.
Lobbying for Pharmaceutical Research and Manufacturers of America (PHRMA)
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 16, 2026
Income
$290,000
What the client paid this registrant for the period.
Client based in
District of Columbia
Lobbying activity
1
Issues related to various healthcare reform and drug pricing.